Clarivate Identifies Seven Innovators in Antibody Drug Conjugates in New Companies to Watch Report
CLVTClarivate(CLVT) Prnewswire·2024-06-19 15:00

Emerging standouts set to transform drug discovery and development, revolutionize cancer treatment, and capture big pharma interest highlighted in third annual report LONDON, June 19, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has released its annual Companies to Watch report, highlighting seven innovative companies revolutionizing drug discovery and development. These companies are advancing antibody-drug conjugates (ADCs) to deliver highly tar ...